Historical record - last NADAC publication: 4/22/2015
Product Information
MORPHINE SULFATE ER 45 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $6.9631 per EA under NDC 00228311611. Its NADAC has been published 78 times since Nov 19, 2014.
The High Outlier badge above means this manufacturer's average price in the Morphine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
45 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228311611
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2015
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA079040On Market Since
2/4/2014
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 45 MG CAP has been published 78 times since Nov 19, 2014, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.9631 per EA |
|---|---|
| All-time high | $6.9631 (May 11, 2016) |
| All-time low | $6.5088 (Nov 19, 2014) |
| Median price | $6.9631 |
| Average price | $6.8349 |
| Largest weekly change | +7.0% (Apr 22, 2015) |
| Weeks tracked | 78 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Morphine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 45 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 45 MG CAP, manufactured by Actavis Pharma, Inc., is $6.9631 per EA (NDC 00228311611), effective May 11, 2016.
How has the price of MORPHINE SULFATE ER 45 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 45 MG CAP has risen 7.0%. It has been tracked across 78 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 45 MG CAP?
Since Nov 19, 2014, the NADAC for MORPHINE SULFATE ER 45 MG CAP has ranged from a low of $6.5088 (Nov 19, 2014) to a high of $6.9631 (May 11, 2016), with a median of $6.9631 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 45 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 45 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 45 MG CAP?
MORPHINE SULFATE ER 45 MG CAP (NDC 00228311611) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification